Blood pressure elevations in riluzole-treated patients with amyotrophic lateral sclerosis

Citation
Sn. Scelsa et I. Khan, Blood pressure elevations in riluzole-treated patients with amyotrophic lateral sclerosis, EUR NEUROL, 43(4), 2000, pp. 224-227
Citations number
10
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
EUROPEAN NEUROLOGY
ISSN journal
00143022 → ACNP
Volume
43
Issue
4
Year of publication
2000
Pages
224 - 227
Database
ISI
SICI code
0014-3022(2000)43:4<224:BPEIRP>2.0.ZU;2-5
Abstract
Objective: To determine whether riluzole is associated with blood pressure elevations in patients with amyotrophic lateral sclerosis (ALS). Background : Though previously reported, hypertension is not considered a frequent adv erse effect of riluzole. Methods: We reviewed data from 35 consecutive ALS patients on riluzole, and 88 randomly selected controls without and 20 pati ents with ALS who were not on riluzole. Results: A significantly greater nu mber of ALS patients on riluzole had blood pressure elevations (28 of 35 pa tients) compared to controls (26 of 88, p < 0.001; 8 of 20, p = 0.007). Med ian systolic and diastolic blood pressures were both significantly higher i n riluzole-treated (140/86 mm Hg) than in control patients without ALS (120 /70 mm Hg, p < 0.001). Systolic, but not diastolic, blood pressures were si gnificantly higher in riluzole-treated patients than in controls with ALS ( 126 mm Hg, p = 0.002). Conclusions: Riluzole treatment may be associated wi th mild blood pressure elevations. Future prospective trials of riluzole sh ould closely assess hypertension. Copyright (C) 2000 S. Karger AG, Basel.